Health:Further

In this deep dive into Healthcare Policy & Regulation with Emily Evans, we discuss the Supreme Court's upcoming review of the Chevron deference and its likely effects on healthcare regulatory agencies including HHS, CMS, FDA and FTC. We also discuss the expected positive impact on healthcare M&A markets. While potential policy changes create short-term uncertainty, they also present opportunities for consolidation, competition, and innovation in the medium to long-term.HF Site YOUTU...

Show Notes

In this deep dive into Healthcare Policy & Regulation with Emily Evans, we discuss the Supreme Court's upcoming review of the Chevron deference and its likely effects on healthcare regulatory agencies including HHS, CMS, FDA and FTC. We also discuss the expected positive impact on healthcare M&A markets. While potential policy changes create short-term uncertainty, they also present opportunities for consolidation, competition, and innovation in the medium to long-term.

HF Site

YOUTUBE
INSTAGRAM
TWITTER
FACEBOOK
LINKEDIN
TIKTOK

What is Health:Further?

Every week, healthcare VCs and Jumpstart Health Investors co-founders Vic Gatto and Marcus Whitney review and unpack the happenings in US Healthcare, finance, technology and policy. With a firm belief that our healthcare system is doomed without entrepreneurship, they work through the mud to find the jewels, highlight headwinds and tailwinds, and bring on the smartest guests to fill in the gaps.